drugset / Trial / NCT06309394

A Study Assessing the Mass Balance, Pharmacokinetics, and Metabolite Profiles of a Single Oral Dose of [14C]INCB099280 in Healthy Male Participants

NCT06309394

Phase 1 Completed 5 enrolled Incyte Corporation
NaSingle-groupOpen-labelTreatment

Summary

This study is being conducted to assess the Mass Balance, Pharmacokinetics, and Metabolite Profiles of a Single Oral Dose of \[14C\]INCB099280 in Healthy Male Participants.

Timeline

Start
2024-05-15
Primary completion
2024-06-04
Completion
2024-06-04

Drugs

EvaluationDrugModalityDoseRoute
Subject INCB099280 Unknown Oral

Indications

No indication recorded.